Streptomyces sp. strain C5, an organism that normally produces baumycins, daunomycin and E-rhodomycinone, was treated with N-methyl-N'-nitro-N-nitrosoganidine (NTG). Mutants blocked at various points in daunomycin and baumycin production were isolated by screening for altered pigmentation and absence of bioactivity against Staphyfococcus aureus. Examination of the mutants by thin-layer chromatography of their accumulated anthracycline metabolites, by cosynthesis assays, and by extract feeding experiments allowed a classification into six groups. These were: dauA, strains that accumulated no anthracyclines but with other blocked mutants cosynthesized anthracyclines (polyketide-synthase-minus mutants); dauG, regulatory mutants that, either alone or mixed with other blocked mutants, accumulated no anthracyclines; d a d , mutants that accumulated aklanonic acid; dauE, mutants that accumulated maggiemycin; dauF, mutants that accumulated aklavinone; and dauH, mutants that accumulated only E-rhodomycinone. Mutant SC5-24 (dauE), which accumulated the shunt product maggiemycin, was re-mutagenized with NTG to obtain blocked mutants in preceding biosynthetic steps; the three groups of double mutants obtained accumulated aklanonic acid (dauC,E), aklanonic acid methyl ester (dauD,E) and aklaviketone (dauE,F).
Introduction
Several streptomycetes produce 7,8,9,1 O-tetrahydro-5,12-naphthacene quinone glycosides, commonly known as anthracyclines (Strohl et al., 1989) . Three such anthracyclines, adriamycin (also known as doxorubicin), daunomycin (also known as daunorubicin) and aclacinomycin A, are used extensively as chemotherapeutic agents but are cumulatively cardiotoxic and have destructive side-effects when used for long periods of time (Arcamone, 1984) . Therefore, new anthracyclines with enhanced clinical properties have been sought intensively (reviewed by Fujiwara & Hoshino, 1983; Strohl et al., 1989) . One of the major difficulties has been the absence of a thorough knowledge of the enzymic reactions and intermediates in the formation of anthracyclines. This knowledge would assist efforts to determine how anthracycline biosynthesis is regulated, to analyse recombinant DNA clones containing anthracycline biosynthesis genes, to construct over-producing t Present address : Department of Microbiology, State University of New York at Stony Brook, Stony Brook, NY 11794, USA.
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0001-6020 0 1990 SGM strains and to design rational interspecies cloning experiments leading to new 'hybrid' anthracyclines with potentially enhanced clinical properties (Strohl et al., 1989) . This paper describes the mutation of the anthracycline-producing strain, Streptomyces sp. C5 (McGuire et al., 1980a, b, c ; Strohl et al., 1989) , the isolation and characterization of blocked mutants, and the location of the blocked steps in the daunomycin biosynthesis pathway.
Methods
Organisms, culture maintenance and growth conditions. Streptomyces sp. strain C5 was used as the parental strain for mutagenesis. Its isolation as a spontaneous and UV-induced, cerulenin-selected, anthracycline-overproducing mutant of an unidentified streptomycete ( Fig. 1) has been described (McGuire er al., 1980a, b, c). Nitratedefined medium (NDM; see accompanying paper: Connors et al., 1990a), yeast/malt agar medium (YMA; Dekleva et al., 1985) and R2YE medium (Hopwood et al., 1985) have also been described.
Spore suspensions for culture storage or mutagenic treatment were prepared from sporulated cultures grown on R2YE agar. Agar plates containing R2YE medium were inoculated with spores of Streptomyces strains and incubated at 30 "C until sporulation, which was usually in 4-8 d. Sterile, acid-washed 3 mm glass beads were rolled over the surface of the culture to collect spores for mutagenic treatment. The beads were transferred to a sterile beaker and the spores were washed P . L. Bartel, N . C. Conmrs and W. R. Strohl researchers at the Frederick Cancer Research Center (McGuire e; al., 1980a, b, c) and the subsequent derivation of SC5-24 and other blocked mutants as described herein.
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from them with water, pelleted by centrifugation (6000g, 10 min) and resuspended in 10% (v/v) glycerol. Spore suspensions were stored at -20 "C until used. For long-term storage, spores were scraped from the surface of sporulated cultures, suspended in Difco nutrient broth (8 g 1-l) containing 10% glycerol, and frozen at -70 "C. Cultures used frequently were stored at room temperature after sporulation. For bioassays Staphylococcus aureus was grown overnight at 37 "C on TSA plates (BBL trypticase soy broth, 30 g; agar, 15 g; distilled water to 1 1) and was stored at 4°C.
Mutagenesis.
Spores were mutagenized by exposure to N-methy1-N'-nitro-N-nitrosoguanidine (NTG ; Sigma) by a slight modification of the method described by Deli6 et al. (1970) . Spore preparations of Streptomyces sp. C5 or SC5-24 (a maggiemycin-accumulating mutant of Streptomyces sp. C5) were pelleted by centrifugation and were resuspended in 50 mM-Tris/maleate buffer, pH 9.0. The spore suspensions were added to pre-weighed crystals of NTG in 1.5 ml microcentrifuge tubes to yield a final NTG concentration of 3 mg ml-l. The suspensions were vortexed vigorously to dissolve the NTG and incubated at room temperature for 90 min. After the spores had been washed four times with water to remove NTG, the titre of survivors was determined by plating on YMA, and the treated spores were resuspended in 10% glycerol for storage at -20 "C.
Isolation of mutants with altered pigmentation. Spores treated with NTG were plated on NDM or R2YE agar at a concentration of 100-200 viable spores per plate and incubated at 30 "C for 4-7 d; colonies were examined for altered pigmentation. Streptomyces sp. C5 sporulates well on both R2YE and NDM media and gives dark-red coloured colonies due to production of various anthracyclines, including Erhodomycinone and baumycins (McGuire et al., 1980c; Strohl et al., 1989) . Colonies with altered pigmentation but otherwise normal colonial morphology were transferred to fresh R2YE plates. Candidate mutants were examined during at least five transfers to ensure that they had stable phenotypes.
Mutants blocked in two steps of daunomycin biosynthesis were generated by treating strain SC5-24 with NTG. Colonies of SC5-24 are blue due to production of maggiemycin (McGuire et al., 1980b) , a putative pathway shunt product (Eckardt & Wagner, 1988) . Mutants which produced yellow or red pigments were chosen from survivors grown on R2YE or NDM agar medium.
Isolation of mutants lacking bioactivity. Mutants inactive against S. auras were detected by a slight modification of the methods used by Motamedi et al. (1986) . NTG-treated spores of Streptomyces sp. C5 were plated on YMA to give about 300 colonies per plate. After 3-4 d incubation at 30 "C, mycelia from individual colonies were transferred to an R2YE agar plug in a 96-well immunoassay plate and to fresh YMA (50 colonies per plate on a grid). The immunoassay plates contained approximately 300 pl R2YE agar medium, prepared as described by Hunter (1985) , per well. The YMA plates were incubated at 30 "C for 2 d and were then stored at 4 "C until needed; the 96-well plates were incubated at 30 "C for 6-8 d. To avoid choosing pleiotropic mutants, bald and dwarf colonies were marked. Bioassay agar was prepared by adding 5 ml of an overnight nutrient broth culture of S. aureus to 125 ml of warm (approx. 45 "C) nutrient agar and dispensed into Petri dishes (about 20ml each). Twenty plugs from the 96-well plates were transferred to each dish and incubated at 37 "C overnight. Plugs which produced no zone of inhibition were noted and the corresponding colonies from the previously incubated Y MA plates were transferred to fresh YMA. The bioassay of these colonies was repeated three more times to ensure that the strains were stable and had no antibiotic activity against S. aureus.
Extraction and analysis of anthracycline metabolites. Spores of mutant strains were spread on R2YE agar and incubated at 30 "C for 4-7 d. A 4 x 4 cm piece of agar supporting an area of confluent growth was removed, cut up and placed in 3ml of methanol. The extraction mixture was incubated at room temperature for 1 h, after which the methanolic extract was decanted, 3 ml each of water and chloroform were added, and the pigments were extracted into the chloroform phase. Alternatively, when the anthracyclines in the extract were hydrolysed to aglycones, 3 ml0-4 M-HCl was added. The mixture was incubated at 90°C for 45min before extraction with 3ml of chloroform. The chloroform extracts were evaporated in vacuo at room temperature. The dried extracts were resuspended in 20 p.1 chloroform for analysis by thin-layer chromatography (TLC) on silica gel (Whatman HP-KP, . Chromatograms were developed with solvent system SS1, chloroform/heptane/methanol (10: 10 : 3, by vol.); SS2, benzene/acetone/methanol (100 : 10 : 1, by vol.) for separation of aglycones (Table 1) ; or SS3, chloroform/methanol/water/glacial acetic acid (80 : 20 : 2 : 0.2, by vol.), for separation and analysis of glycones. Compounds resolved from extracts by TLC were compared to authentic anthracyclines and anthracyclinone intermediates ( Table 1) .
The RF values, colouration in acid and alkali, and fluorescence of the zones irradiated at 365 nm were also compared with standards ( Table 1) .
Analysis of cocultured mutant strains. Four patches of approximately 4 x 4 cm, each containing spores from two mutants on R2YE agar were incubated at 30 "C for 5-7 d. Pieces of agar containing the patches were then removed and extracted as described. The extracts were analysed by TLC for the production of daunomycinone (after hydrolysis with HCl as described above) or baumycins (non-hydrolysed samples). Analysis of mutants by extract feeding. Spores of a mutant strain were swabbed over the entire surface of an R2YE agar plate and incubated for 7 d, after which the agar was extracted at room temperature for 1 h with 25 ml methanol. The methanolic extract was concentrated in uacuo and the amount produced by a culture on one Petri dish was incorporated into a dish of fresh R2YE medium. Four mutant strains were patched individually on each extract-containing plate and incubated at 30°C for 5d, after which the patches were cut out, extracted and examined for baumycins by the methods described for the cosynthesis assays. Representative strains from each class of mutants were used to prepare extracts and to convert extracts from other strains.
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Standards. Authentic standards for anthracyclines and anthracyclinones were obtained from Adria, the Frederick Cancer Research Center and Rh6ne-Poulenc. Authentic samples of aklanonic acid, aklanonic acid methyl ester (AAME) and aklaviketone were obtained from Klaus Eckardt and his colleagues of the Academy of Sciences, Jena, GDR.
Results
Streptomyces sp. C.5 mutants blocked in anthracycline biosynthesis
Streptomyces sp. strain C5 grown in nutrient-rich media for 5-7 d normally accumulates about 20 mgl-l of aglycones, the major species of which is E-rhodomycinone, and about 2 mg I-' of glycosides, of which there are seven separable forms (P. L. Bartel, J. Duddy & W. R. Strohl, unpublished) . Since the final glycosidic products of Streptomyces sp. C5, e.g. daunomycin and baumycins A and B, are orange-to-red pigments active against Staphylococcus aureus, both the absence of normal pigmentation and lack of bioactivity were used as indicators in screening for blocked mutants. Treatment of Streptomyces sp. C5 spores with NTG left 0.93% survivors, of which a total of approximately 80000 were examined for pigmentation and absence of activity against S . aureus. Over 100 blocked mutants were obtained and analysed in greater detail. All of them displayed normal developmental phenotypes, i.e. they formed aerial mycelia and spores and grew to the normal size.
Of 62000 colonies from NTG-treated spores plated on either NDM or R2YE and closely examined for altered pigmentation, several hundred with altered pigmentation were isolated. After at least five transfers to examine the stability of the mutations, 101 mutants stably exhibited altered pigmentation but still grew and sporulated normally. In a separate mutant isolation experiment, 12 000 colonies derived from NTG-treated spores were screened by bioassay against S. aureus. Using this method, 12 mutant colonies with no bioactivity were isolated (irrespective of colony pigmentation). In a third experiment, four red-pigmented mutants which did not possess bioactivity against S. aureus were detected out of 5000 red colonies screened. In all, 117 stable, blocked mutants were obtained out of 79000 colonies screened, yielding a frequency of 1.28 x
Analysis of anthracycline metabolites accumulated by blocked mutants
The anthracycline metabolites accumulated by each of the 117 mutant strains were extracted with organic solvents and analysed by TLC. The strains were classified into groups based on the type of anthracycline metabolites they accumulated ( Table 2 ). The largest group (30 cream-coloured mutants) sporulated normally but failed to accumulate any anthracycline-like metabolites. Three reddish-yellow mutants accumulated t Red-pigmented mutants detected by bioassay; 9 dauH mutants were isolated from 17000 colonies examined.
aklanonic acid, four blue-pigmented mutants accumulated maggiemycin, and seven yellow mutants accumulated aklavinone. Nine red mutants accumulated E-rhodamycinone, but a few of these also accumulated small amounts of other biologically inactive, pigmented metabolites. These other metabolites did not comigrate with any standards that were available (data not shown). A large group of 35 mutants accumulated normal amounts of glycosylated end products, i.e. baumycins, but failed to accumulate any c-rhodomycinone (data not shown).
Finally, a group of leaky mutants accumulated small quantities of several compounds, at least one of which was bioactive. The leaky strains and those that accumulated only baumycins were not included in any further analyses.
Mutagenesis of SC5-24 and isolation of additional blocked mutants
Eckardt & Wagner (1988) postulated that AAME and aklaviketone were intermediates in the formation of crhodomycinone. We did not find, however, any NTGinduced mutants of Streptomyces sp. C5 that accumulated these postulated aglycone intermediates. We hypothesized that this might have been due to our inability to distinguish the slight changes in pigmentation exhibited by colonies excreting these compounds, which are reddish to red-brown in colour. Therefore, mutant strain SC5-24, a blue-pigmented, maggiemycinaccumulating mutant (Figs 1 and 2 ; Table 2 ), was remutagenized with NTG and survivors, plated on R2YE medium, were screened for altered pigmentation. The frequency of such colonies was 6 x and no revertants to the Streptomyces sp. C5 phenotype were observed among the 50000 colonies screened. From the total of 30 NTG-induced mutants of SC5-24, two reddish colonies accumulated aklanonic acid, three brownpigmented mutants accumulated AAME, 13 reddish blocked mutants accumulated aklaviketone, and the remainder did not accumulate any pigmented metabolites (Table 2 ). All three of the AAME-accumulating strains also produced small quantities of maggiemycin in addition to AAME. Several of the aklaviketone accumulators also accumulated small quantities of maggiemycin. Since maggiemycin and aklaviketone were not separable on TLC plates (although their pigmentation and fluorescence differ considerably), the accumulation of aklaviketone by these strains was confirmed by separation with HPLC as described in the accompanying paper (Connors et al., 1990a).
Analysis of the cosynthetic behaviour of blocked mutants
Attempts to cosynthesize glycone end-products (e.g. daunomycin and baumycins) by growing mutant strains together in liquid medium (Blumauerovi et al., 1979) , or by growing mutant strains adjacently on agar medium (Deli6 et al., 1969; Rudd & Hopwood, 1979), were unsuccessful. However, when spores of two mutant strains were mixed and then grown together on agar medium as a coculture, they cosynthesized baumycins that were detectable by TLC. The cosynthesis assays, in conjunction with analysis of intermediates accumulated by the mutants in each group, placed the mutants in six distinct cosynthetic classes ( Table 2) . Mutants of classes A, C, E, F and H cosynthesized baumycins when mixed with mutants of all classes except G and those of the same class. Mutants of classes A and G, which were cream-pigmented and did not accumulate any anthra- 
Extract feeding experiments to establish a biosynthetic sequence
The cosynthesis assays did not allow determination of the polarity of the reactions (i.e. which strain was secreting and which was converting). To determine the biosynthetic sequence represented by the mutants, a series of extract feeding experiments was conducted using representative (or 'type') strains from each mutant class ( Table 3) . The dauA strain could convert extract from most of the other strains tested (except dauE) to glycosides; the dauF strain, SC5-31, and the dauH strains, SC55 and SC5-58, produced compounds that could be converted to glycosides by strains from classes dauA, dauC and dauE ( Table 3) . The dauE mutant, SC5-24, which accumulated maggiemycin, converted extracts from classes dauF and dauH. Extracts from the dauE mutant, however, were not converted to daunomycin or baumycins by any of the mutants tested ( Among the mutants of Streptomyces sp. C5 was a large group of strains that did not accumulate any detectable anthracycline-like compounds (based on pigments, fluorescence and RF after separation by TLC), but which still cosynthesized baumycins with a variety of strains from the other blocked mutant classes. These were assigned to the earliest step in the biosynthetic sequence by extract feeding experiments. This class of mutants, designated dauA, appears to represent strains that are mutated within the postulated 'polyketide synthase complex', a group of enzymes thought to be responsible for the successive condensation of malonyl-CoA units to a propionyl-CoA starter unit to produce aklanonic acid (Eckardt & Wagner, 1988 ; Strohl et al., 1989) . Although very little is currently known about the anthracycline polyketide synthase system, it is believed to be similar to those of other streptomycete polyketide synthase systems, which are composed of a P-ketoacyl synthase, a poly-P-ketone cyclase and an ACP-like protein Sherman et al., 1989) . The production of a stable polyketide compound may also require the action of a P-keto reductase (Hallam et al., 1989) . Our dauA class of mutants probably contains strains which are mutated in different proteins of the polyketide synthase complex, but the determination of this will have to await genetic analysis. From daunomycin-producing strains of S. griseus, IMET JA 3933, IMET JA 5142 and IMET JA 5570, thirty-two mutants have previously been isolated, which differ from one another in the amounts of daunomycin produced (Strauss & Fleck, 1975 ; Wagner et al., 198 1,1985) . The largest class (14 members) was made up of mutants that accumulated no anthracycline metabolites. These mutants, designated class I or lkml, were probably blocked in the polyketide synthase complex (Wagner et al., 1981) , like our class of Streptomyces sp. C5 dauA mutants. Eckardt et al. (1985) isolated aklanonic acid, an anthraquinone metabolite accumulated by Streptomyces sp. ZIMET 437 17, and showed that this compound and its chemically produced methyl ester could be converted in vivo by blocked mutants of the daunomycin-producing strain, S. griseus IMET JA 5142, to aklavinone, an intermediate in daunomycin biosynthesis . They also showed that S . peucetius strain 21/8 and S. galilaeus strain S727 could convert aklanonic acid to anthracyclinones similar to aklavinone (Schumann et al., 1986) . Eckardt & Wagner (1988) recently proposed a pathway for anthracyclinone biosynthesis in which aklanonic acid was the first stable intermediate after cyclization and aromatization of the polyketide precursor, and was converted to aklavinone and c-rhodomycinone. Strains of the Streptomyces sp. C5 mutant class dauC, which accumulate aklanonic acid, appear to be similar to blocked mutants of S . peucetius 601-FI and S . galilaeus F 198 which also accumulate aklanonic acid (Schlegel et al., 1987) . Thus it appears that aklanonic acid is a primary intermediate in the daunomycin production pathway of several organisms (Eckardt & Wagner, 1988 ). An anthraquinone intermediate, similar to aklanonic acid, also has been implicated in oxytetracycline biosynthesis (Thomas & Williams, 1983) . This suggests that aklanonic acid or analogous anthraquinones may be universal intermediates in the formation of various naphthacenequinone polyketides. AAME and aklaviketone have previously been converted to anthracyclines in vivo Eckardt et al., 1985; Schumann et al., 1986) . When spores of the maggiemycin-accumulating dauE mutant, SC5-24, were treated with NTG, doubly-mutated strains that accumulated aklanonic acid (dauC, E), AAME (dauD, E ) or aklaviketone (dauE, F ) were isolated. Eckardt & Wagner (1988) proposed that aklaviketone is an intermediate to maggiemycin formation. If this is true, then aklaviketone appears to be a substrate for the formation of both aklavinone by a reduction at C-7 and for maggiemycin by hydroxylation at C-11 ( Fig. 2 ; Connors et al., 1990a) . Thus, the only way in which an aklaviketone accumulating mutant could be obtained would be to have a double mutant (aklaviketone 7-reductase-and C-1 1 hydroxylase-deficient), so that aklavinone would not be produced as an intermediate, and aklaviketone accumulated would not be utilized as a C-1 1 hydroxylase substrate (producing maggiemycin). Our data, in this and an accompanying paper (Connors et al., 1990 a) , indicate that these hypotheses are correct.
There are two possible reasons why we were unable to find a strain that accumulated AAME by screening mutants of Streptomyces sp. C5 for altered pigmentation or by bioassay. The first is that AAME-accumulating strains are similar in colour to the wild-type strain. Mutants accumulating AAME have not been isolated previously, suggesting that, in vivo, AAME might be converted to aklaviketone by a chemical rather than by an enzymic reaction (Eckardt & Wagner, 1988) . The fact that we isolated double mutants (dauD, E ) that accumulated AAME indicates that the cyclization is enzymecatalysed. Moreover, AAME was the predominant product of the in vitro conversion of aklanonic acid by strain SC5-138, a dauD, E double mutant (Connors et al., 1990a) . The reason these mutants are slightly leaky (i.e. produce small quantities of maggiemycin) is probably that AAME can be chemically cyclized, yielding four possible stereoisomers. Although three of the chemicallyformed isomers would probably not be biologically active, the fourth would be aklaviketone. Without a second mutation, these leaky mutants probably would have formed enough aklaviketone to synthesize glycosides that would have inhibited S. aureus. This provides the second reason why it is unlikely that we would have found AAME-accumulating mutants by direct mutation of Streptomyces sp. C5. Although no mutant accumulating AAME had previously been isolated, anthraquinone methyl esters structurally similar to AAME have been isolated from culture supernatants of S . galilaeus ANR-58 and ANR-665 mutant strains (Tobe et al., 1982) , S . galilaeus J-14 (Krilovkovk et al., 1980) and S . coeruleorubidus 24-27 (type E) (Jizba et al., 1980) .
McGuire et al. (1980 6 ) isolated the 7-0XO anthracyclinone, maggiemycin (described in detail by Pandey et al., 1989) , from a mutant strain, A21, which is related to Streptomyces sp. C5 (Fig. 1) . recently isolated the brown-red 7-0x0 anthracyclinone, aklaviketone, from cultures of a mutant of S. galilaeus S-383. Aklaviketone, which is 1 1-deoxymaggiemycin, was shown to be an intermediate in the formation of aklavinone Eckardt & Wagner, 1988) . The NAD(P)H-dependent reduction of aklaviketone at C-7 results in the formation of aklavinone (Connors et al., 1990a) . Our strain, SC5-24, and other dauE mutants, accumulated maggiemycin and are therefore similar to the maggiemycin-accumulating strain A2 1 previously described (Fig. 1) . Similarly, among the blocked mutants of S. griseus IMET JA 3933 were four 'class VI' mutants that were coloured a deep blue-violet and were shown to accumulate anhydromaggiemycin (Ihn et al., 1984) , indicating that they were probably also aklaviketone reductase mutants. According to the hypothesis proposed by Eckardt & Wagner (1 988) , maggiemycin-accumulating strains are deficient in their ability to convert aklaviketone to aklavinone, which is the normal C-11 hydroxylase substrate. In the absence of the aklavinone reductase, aklaviketone accumulates and is apparently hydroxylated at C-1 1 to produce maggiemycin (Connors et al., 1990a) . The extract feeding experiments indicated that maggiemycin produced by the dauE mutants is not converted to glycosides, even though the dauE mutant could convert intermediates excreted by other, later mutants, to glycosides. These data, along with experiments showing that maggiemycin cannot be converted to erhodomycinone in vitro (Connors et al., 1990a) , demonstrate that maggiemycin is a shunt product of dauE mutants blocked in daunomycin production, rather than an intermediate in the biosynthesis pathway (Fig. 2) .
The anthracycline intermediate 6-rhodomycinone is found in most daunomycin fermentations Strohl et al., 1989) . &-Rhodomycinone is formed by hydroxylation of aklavinone at C-1 1 (Connors et al., 1990a) . Whereas most early intermediates in the anthracycline biosynthesis pathway are yellow, c-rhodomycinone and other compounds containing the C-1 1 hydroxyl group are red or orange (reviewed by Strohl et al., 1989). Aclacinomycin-type antibiotics which incorporate aklavinone as their chromophore are produced by strains (e.g. S . galilaeus) which do not hydroxylate aklavinone at the C-11 position (Oki et al., 1979) . Mutants such as S . peucetius var. aureus (ATCC 31428), which are presumably deficient in the C-11 hydroxylation step, accumulate aklavinone and 1 1-deoxy derivates of daunomycin (Cassinelli et al., 1982) . The seven dauF mutants of Streptomyces sp. C5 accumulated aklavinone and lacked aklavinone 1 1-hydroxylase activity as shown by in vitro reactions reported in the accompanying paper (Connors et al., 1990~) . Similarly, Wagner et al. (1981) isolated four 'class 11' mutants of S . griseus that produced several yellow compounds which were later identified as 1 1-deoxydaunomycin analogues . These strains also probably lacked the C-1 1 hydroxylase function which normally converts aklavinone to Erhodomycinone.
A group of nine mutants, comprising the dauH class, accumulated c-rhodomycinone but no glycosides. Whereas most blocked mutants were isolated at a frequency of about 6-8 x dauH mutants were isolated at a frequency of 5.3 x ( Table 2 ), suggesting that any of several different genes could be mutated to obtain the same phenotype. Similar results were found with S . griseus, where mutants in class V were heterogeneous and consisted of eight strains that accumulated &-rhodomycinone and some other minor red compounds ( The biosynthetic sequence deduced from our accumulated data is shown in Fig. 2 . Feeding experiments suggested that dauA mutants carry the earliest block in the order of reactions. This is consistent with their failure to accumulate any detectable anthracycline intermediates -they do not feed other blocked mutants -or to convert extracts from dauC, dauF and dauH mutants to glycosides. The next step in the biosynthetic sequence is represented by the dauC mutants; these accumulate aklanonic acid, can feed dauA mutants, and can be fed by dauD,E and dauH mutants. The dauD,E double mutants, which accumulate AAME and feed dauC mutants, are positioned next, followed by the dauE,F double mutants, strains that accumulate aklaviketone. The next group consists of the dauF mutants which accumulated aklavinone, were able to feed the dauA, dauD, E and dauE mutants, and were fed by some dauH mutants. The dauH mutants are placed at the final step of the reaction sequence, because they accumulated Erhodomycinone and fed dauA, dauC, dauE, dauE, F and dauF mutants.
Compounds in extracts made from cultures of the dauG strain, SC5-38, could not be converted to glycosides, nor did this strain convert any compounds produced by other strains (Table 2) . Similarly, the dauG strains did not cosynthesize glycosides with any strains, except inconsistently with dauE strains (data not shown). Furthermore, dauG mutants were unable to support the expression of the actinorhodin biosynthesis genes, actI, act111 and actVII (P. L. Bartel and others, unpublished data) , whereas the actinorhodin genes were expressed when transformed into blocked mutants from other classes (reviewed by Strohl et al., 1989; P. L. Bartel and others, unpublished data Mutant classes A, C, D-E, E-F, F and H are ordered based on their accumulated metabolites and the results of cosynthesis assays and extract feeding experiments. Class E mutants accumulated maggiemycin, which could not be converted in uiuo (this paper) or in uitro (Connors et a/., 1990a) to other anthracyclines, indicating that it is a shunt product. The second half of the pathway, from c rhodomycinone to carminomycin and daunomycin is described by Connors er a/. (1990b).
were found other than the absence of anthracycline formation. Thus, it appears that the dauG strains are dauminus regulatory mutants which may be analogous to act11 mutants of S . coelicolor (Rudd & Hopwood, 1979; Hallam et al., 1989) .
Although about 80000 mutants were screened, none appeared to be affected in the reaction between Erhodomycinone and daunomycin. Both Streptomyces SP. C5 (McGuire et al., 1980c) and S . coeruleorubidus M E 130-A4 (Yoshimoto et al., 1980) convert &-rhodomycinone to glycosides of daunomycinone, demonstrating that c-rhodomycinone is an intermediate of daunomycin biosynthesis. The sequence of enzymic reactions from Erhodomycinone to daunomycin is considerably less clear than the sequences preceding 8-rhodomycinone (see accompanying paper: Connors et al., 1990b), but the following must take place: (i) removal of the methyl group at C-15; (ii) decarboxylation at C-10; (iii) two-step oxidation from a methylene to a keto group at C-13; (iv) O-methylation of the C-4 hydroxyl group; and (v) glycosylation with daunosamine of the C-7 hydroxyl group (see Fig. 2; Strohl et a f . , 1989) . We have recently proposed, from data in the literature and some of our own results, a biochemical sequence for these reactions (Strohl et al., 1989) . Our hypothetical sequence includes the glycosylation of c-rhodomycinone to rhodomycin, which then would be demethylated and decarboxylated at C-10, followed by oxidation at C-13, and finally 0-methylation at C-4 (Connors et al., 1990b) . I f this sequence of reactions is correct, then all intermediates in the pathway after erhodomycinone are red-to orangepigmented glycosides that would inhibit our test organism. Therefore, our primary screening procedures would not have detected mutants blocked in the pathway after c-rhodom yc inone formation.
Stutzman-Engwall & Hutchinson (1 989) recently cloned five distinct, non-overlapping regions of D N A from S . peucetius ATCC 29050, four of which may be involved in anthracycline production. Group IV DNA directed the biosynthesis of erhodomycinone in S . lividans and caused the production of 100-fold more c-rhodomycinone in S . peucetius strain H6125 (StutzmanEngwall & Hutchinson, 1989) . Southern hybridization indicated that DNA isolated from Streptomyces sp. C5 had homologous regions in common with DNA within gene clusters I11 and IV from S . peucetius ATCC 29050. Recent data indicate that the group IV cluster, along with DNA contiguous to it, probably encodes daunomycin formation in S . peucetius ATCC 29050 (StutzmanEngwall & Hutchinson, 1-989). We have recently subcloned a 2.0 kb SstI fragment from the group IV gene cluster from S . peucetius ATCC 29050 that complemented the dauE (aklaviketone reductase) mutation in Streptomyces sp. C5 mutant strain SC5-138. Similarly, we have subcloned from the group IV cluster a non-overlapping 6 kb SstI DNA fragment that complemented both dauC and dauD mutants (T. Miller, P. L. Bartel & W. R. Strohl, unpublished) . These experiments indicate that the mutants of Streptomyces sp. C5 we have obtained will be useful for analysing the anthracycline biosynthesis gene clusters recently isolated from S . peucetius ATCC 29050 .
